What is the interpretation of a Total Iron Binding Capacity (TIBC) of 76, Transferrin (Tf) of 3.03, TIBC saturation (TIBC SAT) of 0.79, Ferritin of 40, and a Complete Blood Count (CBC) showing Microcytosis (Mean Corpuscular Volume (MCV) of 74), Hypochromia (Mean Corpuscular Hemoglobin (MCH) of 23), and an elevated Red Cell Distribution Width (RDW) of 22.8?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

These lab values are consistent with iron deficiency anemia, and the patient should be treated with oral iron supplementation to replenish iron stores and improve quality of life. The low serum iron (45.0), low transferrin saturation (0.79%), and low MCV (74) and MCH (23) indicate microcytic, hypochromic anemia characteristic of iron deficiency, as supported by the British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults 1. The elevated red cell distribution width (22.8) further supports this diagnosis, showing increased variation in red blood cell size. The ferritin level of 40 is borderline low, though not severely depleted, and according to the guidelines, an SF value above 150 μg/L is unlikely to occur with absolute iron deficiency, even in the presence of inflammation, but a cut-off of 45 μg/L provides a respectable specificity of 0.92 for iron deficiency 1. Key points to consider in the treatment plan include:

  • Oral iron supplementation, typically ferrous sulfate 325mg taken 1-3 times daily between meals with vitamin C to enhance absorption
  • Therapy should continue for 3-6 months to replenish iron stores even after hemoglobin normalizes
  • Investigating the cause of iron deficiency is essential, considering possibilities such as blood loss (menstruation, gastrointestinal bleeding), malabsorption, or dietary insufficiency
  • Side effects of iron therapy may include constipation, nausea, and black stools
  • If oral iron is not tolerated or ineffective, intravenous iron formulations may be considered
  • Dietary counseling to increase iron-rich foods should complement pharmacological treatment.

From the Research

Interpretation of Laboratory Results

The provided laboratory results are:

  • TIBC iron: 45.0
  • Transferritin: 3.03
  • TIBC: 76
  • TIBC SAT: 0.79
  • Ferritin: 40
  • CBC:
    • MCV: 74
    • MCH: 23
    • Red cell distribution width: 22.8

Diagnosis of Microcytic Anemia

The patient's MCV is 74, which is below the normal range, indicating microcytic anemia 2, 3, 4. Microcytic anemia is defined as the presence of small, often hypochromic, red blood cells in a peripheral blood smear and is usually characterized by a low MCV (less than 83 micron 3) 2.

Iron Deficiency Anemia

The serum ferritin level is 40, which is within the normal range, but the transferrin saturation (TIBC SAT) is 0.79, which is low 5, 6. The total iron-binding capacity (TIBC) is 76, which is elevated 5. These results suggest that the patient may have iron deficiency anemia, but the diagnosis is not definitive without further evaluation 2, 5, 3, 4, 6.

Differential Diagnosis

Other causes of microcytic anemia, such as thalassemia, anemia of chronic disease, and sideroblastic anemia, should be considered 2, 5, 3, 4. Further testing, such as hemoglobin electrophoresis, may be necessary to differentiate between these conditions 5, 3.

Evaluation and Management

The patient's underlying cause of iron deficiency anemia should be investigated, and treatment should be tailored to the underlying cause 2, 5, 3, 4, 6. Oral iron supplementation is typically the first-line treatment for iron deficiency anemia, but intravenous iron may be necessary in certain cases, such as malabsorption or ongoing blood loss 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of microcytosis.

American family physician, 2010

Research

Microcytic anemia.

American family physician, 1997

Research

[Microcytic and hypochromic anemias].

Vnitrni lekarstvi, 2001

Related Questions

What is the meaning of low Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), and Mean Corpuscular Hemoglobin Concentration (MCHC) in a Complete Blood Count (CBC)?
What is the significance of a Red Blood Cell (RBC) count of 5.23, Mean Corpuscular Volume (MCV) of 75.4, Mean Corpuscular Hemoglobin (MCH) of 22.4, Mean Corpuscular Hemoglobin Concentration (MCHC) of 29.7, and Red Cell Distribution Width (RDW) of 15.1 in a complete blood count (CBC) with otherwise unremarkable results?
What is the cause of microcytic anemia with normal to elevated ferritin (iron storage protein) levels, specifically a ferritin level of 152?
What is the management approach for a patient with a complete blood count (CBC) showing microcytosis?
What is the treatment for microcytic anemia?
What is the difference between cyproheptadine, diphenhydramine (Benadryl) and cetirizine (Zyrtec)?
What is the best antibiotic for contact use?
What is the best antibiotic for eye infections in patients with contact lens use?
What is a normal Creatine Phosphokinase (CPK) level after weight lifting in a 22-year-old muscular African American male?
What is the diagnosis for a patient with a history of slightly elevated plasma metanephrines, normal 24-hour urine collection for metanephrines and catecholamines, normal 24-hour 5-Hydroxyindoleacetic acid (5-HIAA), normal Thyroid-Stimulating Hormone (TSH) and free thyroxine (FT4), presenting with symptoms of facial numbness, tingling, and flushing, as well as a history of complex migraines, positive Antinuclear Antibody (ANA), pre-diabetes, and hypertension?
What is the role of Olanzapine (Zyprexa) in the management of Intensive Care Unit (ICU) delirium?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.